EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.2.4 | 0.168 | - |
thymidine | - |
Homo sapiens | |
2.4.2.4 | 1.72 | - |
5'-deoxy-5-fluorouridine | - |
Homo sapiens | |
2.4.2.4 | 13.3 | - |
1-(Tetrahydro-2-furanyl)-5-fluorouracil | - |
Homo sapiens | |
2.4.2.4 | 47.6 | - |
uridine | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.4 | Homo sapiens | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.4.2.4 | partial | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.2.4 | gastrointestinal cancer cell | poorly differentiated adenocarcinoma | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.4 | 1-(tetrahydro-2-furanyl)-5-fluorouracil + phosphate | i.e. Tegafur | Homo sapiens | ? | - |
? | |
2.4.2.4 | 5'-deoxy-5-fluorouridine + phosphate | 5'-DFUR | Homo sapiens | 5-fluorouracil + 5-deoxyribose-1-phosphate | - |
? | |
2.4.2.4 | additional information | the phosphorolytic acitvities towards thymidine, 5'-deoxy-5-fluorouridine and 1-(tetrahydro-2-furanyl)-5-fluorouracil remain closely parallel during purification | Homo sapiens | ? | - |
? |